PDR001
Showing 1 - 25 of 90
Metastatic Colorectal Cancer Trial in Boston (Dabrafenib, Trametinib, PDR001)
Recruiting
- Metastatic Colorectal Cancer
- Dabrafenib
- +2 more
-
Boston, Massachusetts
- +1 more
Jun 24, 2022
NSCLC (NSCLC) Trial in Tampa (PBF-509_80 mg, PBF-509_160 mg, PBF-509_320 mg)
Completed
- Non-small Cell Lung Cancer (NSCLC)
- PBF-509_80 mg
- +8 more
-
Tampa, FloridaH.Lee Moffitt Cancer center
Jan 3, 2022
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)
Active, not recruiting
- Leukemia
- +7 more
- Decitabine
- +3 more
-
Boston, Massachusetts
- +10 more
Jan 19, 2023
Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer, HER2-Negative Breast Cancer, Metastatic Epithelial Ovarian Cancer
Terminated
- Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer
- +2 more
- Ribociclib
- +2 more
-
Boston, Massachusetts
- +2 more
Mar 16, 2022
NSCLC (NSCLC), Triple Negative Breast Cancer (TNBC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in Worldwide (NZV930, PDR001,
Terminated
- Non-small Cell Lung Cancer (NSCLC)
- +6 more
- NZV930
- +2 more
-
Tampa, Florida
- +9 more
Nov 2, 2022
Metastatic and Advanced Solid Tumors Trial in United States (NIZ985, PDR001)
Completed
- Metastatic and Advanced Solid Tumors
- NIZ985
- PDR001
-
Bethesda, Maryland
- +6 more
Mar 22, 2022
Metastatic Colorectal Cancer Trial in Sutton (PDR001, bevacizumab, mFOLFOX6)
Terminated
- Metastatic Colorectal Cancer
- PDR001
- +2 more
-
Sutton, Surrey, United KingdomNovartis Investigative Site
Oct 7, 2021
Multiple Myeloma Trial in Worldwide (PDR001, CJM112, LCL161)
Completed
- Multiple Myeloma
- PDR001
- +2 more
-
Phoenix, Arizona
- +7 more
Feb 7, 2022
Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID
Active, not recruiting
- Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
- +2 more
- Dabrafenib
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Aug 9, 2022
NSCLC Trial in Worldwide (PDR001, Cisplatin, Gemcitabine)
Terminated
- Non-small Cell Lung Cancer
- PDR001
- +6 more
-
Fayetteville, Arkansas
- +22 more
Aug 11, 2022
Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma Trial in Worldwide (PDR001, ACZ885, CJM112)
Completed
- Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma
- PDR001
- +4 more
-
Baltimore, Maryland
- +22 more
Mar 15, 2022
Gastrointestinal Stromal Tumors Trial in Seoul (PDR001, Imatinib)
Recruiting
- Gastrointestinal Stromal Tumors
- PDR001, Imatinib
-
Seoul, Korea, Republic ofAsan Medical Center
Jun 22, 2021
Nasopharyngeal Carcinoma Trial in Worldwide (Spartalizumab, Investigator choice of chemo)
Completed
- Nasopharyngeal Carcinoma
- Spartalizumab
- Investigator choice of chemotherapy
-
Marietta, Georgia
- +17 more
Jan 17, 2022
Advanced Hepatocellular Carcinoma Trial in Worldwide (PDR001, INC280)
Completed
- Advanced Hepatocellular Carcinoma
- PDR001
- INC280
-
Toronto, Ontario, Canada
- +16 more
Jul 29, 2021
Oesophageal Adenocarcinoma, Gastric Adenocarcinoma Trial in France (Capmatinib, Spartalizumab)
Suspended
- Oesophageal Adenocarcinoma
- Gastric Adenocarcinoma
-
Besançon, France
- +6 more
Feb 1, 2023
Histologically Confirmed Unresectable or Metastatic Squamous Cell Carcinoma of the Esophagus Who Failed on Standard Treatment
Active, not recruiting
- Histologically Confirmed Unresectable or Metastatic Squamous Cell Carcinoma of the Esophagus Who Failed on Standard Treatment
- PDR001
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
May 5, 2021
Small Cell Lung Cancer, Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in United States (PDR001, LAG525)
Completed
- Small Cell Lung Cancer
- +7 more
- PDR001
- LAG525
-
San Francisco, California
- +19 more
May 4, 2022
Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Trial in
Completed
- Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma
- PDR001
- +5 more
-
Santa Monica, California
- +24 more
Mar 11, 2022
Gastric Cancer by AJCC V8 Stage, Resectable Carcinoma Trial in Caen (perioperative treatment)
Recruiting
- Gastric Cancer by AJCC V8 Stage
- Resectable Carcinoma
- perioperative treatment
-
Caen, FranceCentre François Baclesse
Jun 28, 2021
Head and Neck Squamous Cell Carcinoma Trial in Taipei (Ribociclib, Spartalizumab)
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
-
Taipei, TaiwanNational Taiwan University Hospital
Apr 19, 2022